18 results
PRE 14A
ABOS
Acumen Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:33pm
to oversee and direct the Company’s business. To that end, the Committee has identified and evaluated nominees in the broader context of the Board’s overall … , select and oversee management, and establish and oversee processes to maintain our integrity. Our Audit Committee has the responsibility to consider
DEF 14A
1jl36 h44
27 Apr 22
Definitive proxy
5:03pm
10-K
bw1 yhlp6cp8m4t
28 Mar 22
Annual report
4:51pm
10-Q
e01jf
16 Aug 21
Quarterly report
4:51pm
424B4
uegi4kgw mr
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-10.1
3opwzmp5hvevy25h
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
pfnwt32fub
24 Jun 21
IPO registration (amended)
8:17am
S-1
yak79fjxmojee3vh
9 Jun 21
IPO registration
5:02pm
S-1
EX-10.1
mb3wmsm6ph
9 Jun 21
IPO registration
5:02pm
DRS/A
EX-10.1
4us 47gt05h2
3 Jun 21
Draft registration statement (amended)
12:00am
DRS/A
o0cpou7 q0i26bor0v22
14 May 21
Draft registration statement (amended)
12:00am
DRS
b0u5pwx sme
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next